Literature DB >> 1972685

Interleukin 2 and interferon-gamma activities of mononuclear cells from regional lymph nodes in patients with gastric cancer.

K Kusugami1, T Matsuura, T Kawase, K Ina, H Matsunaga, Y Kuwahara, T Inagaki, K Morise, K Shimokata.   

Abstract

The interleukin 2 (IL-2) and interferon-gamma (IFN-gamma) activities of regional lymph node mononuclear cells (LNMC) were studied in 22 patients with gastric cancer. Regional LNMC could produce high levels of IL-2 and IFN-gamma independent of the disease extension or the location of the lymph nodes. The activities of peripheral blood mononuclear cells (PBMC) from cancer patients were decreased especially in advanced disease compared to controls. The lymph node CD4+ cells were responsible for the bulk of IL-2 activity, whereas both CD4+ and CD8+ cells were equally capable of producing IFN-gamma. The proportion of T cells in LNMC was similar to that seen in PBMC, however, CD4+ cells predominated over CD8+ cells in the lymph nodes, contributing to higher activities of IL-2 and IFN-gamma in LNMC. Furthermore, significant cytotoxic activity could be induced from PBMC using the culture supernatant derived from autologous LNMC in cancer patients. This study suggests that regional lymph nodes are strategically located near the tumor and the local cells are capable of producing high levels of IL-2 and IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972685     DOI: 10.1007/bf02779443

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  30 in total

1.  Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer.

Authors:  Y Kuwahara; K Kusugami; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1987-08

2.  Studies on the pathogenicity of human-origin parainfluenza virus in the brain of mice.

Authors:  K Shimokata
Journal:  Microbiol Immunol       Date:  1978       Impact factor: 1.955

3.  Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.

Authors:  K Kusugami; K R Youngman; G A West; C Fiocchi
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

4.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

5.  Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.

Authors:  B M Vose; F Vánky; E Klein
Journal:  Int J Cancer       Date:  1977-12-15       Impact factor: 7.396

6.  Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.

Authors:  H Matsunaga; Y Kuwahara; K Kusugami; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1988-10

7.  Production of interleukin 2 by human lymph nodes.

Authors:  T Akiyoshi; F Koba; T Kikuchi; S Arinaga; H Tsuji
Journal:  Immunobiology       Date:  1987-05       Impact factor: 3.144

8.  Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma.

Authors:  F Koba; T Akiyoshi; S Arinaga; T Wada; H Tsuji
Journal:  Jpn J Surg       Date:  1987-03

9.  Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture.

Authors:  T A Luger; J S Smolen; T M Chused; A D Steinberg; J J Oppenheim
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

10.  Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.

Authors:  Y Murakawa; S Takada; Y Ueda; N Suzuki; T Hoshino; T Sakane
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

View more
  1 in total

1.  Impaired regulation of natural killer cells in immunoglobulin synthesis by peripheral blood mononuclear cells from patients with ulcerative colitis.

Authors:  T Kawase; K Kusugami; H Matsunaga; T Matsuura; K Morise
Journal:  Gastroenterol Jpn       Date:  1990-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.